Clinical importance of high- sensitivity troponin T in patients without coronary artery disease

North Clin Istanb. 2020 Apr 9;7(3):305-310. doi: 10.14744/nci.2019.71135. eCollection 2020.

Abstract

Cardiac troponin is the preferred biomarker for the diagnosis of the acute coronary syndrome (ACS), but many other diseases can be identified with elevated troponin levels in the absence of ACS. The recent development of a high-sensitive cardiac troponin T (hs-cTnT) assay permits the detection of very low levels of cTnT. The use of hs-cTnT assay has emerged as a tool for identifying high-risk individuals for primary preventive treatment and can detect subclinical injury in asymptomatic patients. Hs-cTnT analyses are generally related to ischemia in the literature. Thus, we made an evaluation of hs-cTnT analysis in non-coronary patients, which may contribute to the literature.

Keywords: Acute myocardial infarction; high sensitive cardiac troponin T; ischemia; subclinical damage.

Publication types

  • Review